Pharmacies - McKnight's Long Term Care News


Medicare drug pricing order could have ‘significant ramifications’ on LTC pharmacies in long run: expert

Long-term care pharmacies could soon be facing “significant ramifications in the long run” following an executive order signed by President Trump on Sunday. That directive states that the Medicare program should not pay more for Part D prescription drugs than the lowest price. More still needs to be known about possible effects, experts caution.

Clinical Briefs for Tuesday, May 12

White House: Test all nursing home residents, staff for COVID-19 over next 2 weeks … Mental health a burden for healthcare workers during pandemic … New task force to develop guidance for reopening senior living and care communities … Alzheimer’s agitation drug shows efficacy in later-phase trial

Clinical Briefs for Thursday, April 23

New technology could block the coronavirus from infecting human cells … Industry at a ‘severe disadvantage’ identifying asymptomatic residents and staff: AHCA/NCAL … Second COVID-19 wave in winter could be worse … Metabolic syndrome and osteopenia in older women tied to socioeconomic status … FDA: Pharmacies may temporarily compound COVID-19 drugs without prescriptions

Next post in News